First Capital Advisors Group, Llc. Biomarin Pharmaceutical Inc Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 200 shares of BMRN stock, worth $13,902. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200Holding current value
$13,902% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.58 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.32 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.31 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$968 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$674 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...